Avacta Group Plc (LON:AVCT – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 57.67 ($0.72) and traded as low as GBX 45.68 ($0.57). Avacta Group shares last traded at GBX 48 ($0.60), with a volume of 1,320,100 shares.
Avacta Group Stock Performance
The business has a 50-day moving average of GBX 50.83 and a 200 day moving average of GBX 57.67. The company has a debt-to-equity ratio of 63.54, a current ratio of 1.29 and a quick ratio of 4.96. The company has a market cap of £169.98 million, a PE ratio of -527.11 and a beta of 1.12.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Articles
- Five stocks we like better than Avacta Group
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Micron Stock Under $100: Seize the AI-Driven Upside
- Dividend Capture Strategy: What You Need to Know
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- How to Read Stock Charts for Beginners
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
